Search filters

List of works by Marie-Jeanne T F D Vrancken Peeters

Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer

scientific article published on May 14, 2013

Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy

scientific article

Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast Cancer

scientific article published on 22 December 2015

Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

scientific article

Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit

scientific article published on 17 October 2018

Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands

article published in 2019

Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit

scientific article published on 25 November 2016

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

scientific article published on 8 August 2009

Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer

scientific article published on 16 August 2010

Diagnosis of breast cancer using diffuse optical spectroscopy from 500 to 1600 nm: comparison of classification methods

scientific article published in August 2011

Discrepancies Between Surgical Oncologists and Plastic Surgeons in Patient Information Provision and Personal Opinions Towards Immediate Breast Reconstruction

Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results

scientific article published on 01 November 2008

Early Assessment of Axillary Response with 18F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla

scientific article published on March 1, 2013

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer

scientific article published on February 12, 2013

Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients

scientific article

Guiding Breast-Conserving Surgery in Patients After Neoadjuvant Systemic Therapy for Breast Cancer: A Comparison of Radioactive Seed Localization with the ROLL Technique

scientific article published on March 6, 2013

Heading toward radioactive seed localization in non-palpable breast cancer surgery? A meta-analysis

scientific article published on 05 September 2014

Hyperspectral Imaging for Resection Margin Assessment during Cancer Surgery

scientific article published on 18 March 2019

Intraoperative 3D Navigation for Single or Multiple 125I-Seed Localization in Breast-Preserving Cancer Surgery

scientific article published on 21 November 2015

Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy

scientific article published on July 28, 2012

MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy.

scientific article published on 21 April 2017

MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy

scientific article published in April 2010

Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype

scientific article published on January 10, 2011

Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

scientific article published on 06 November 2018

Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials

scientific article published in August 2017

On the feasibility of MRI-guided navigation to demarcate breast cancer for breast-conserving surgery

scientific article published in June 2010

Outcome of low-volume surgery for esophageal cancer in a high-volume referral center

scientific article

Paclitaxel, carboplatin, and trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer

scientific article

Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer

scientific article published in March 2010

Quality control of colorectal surgery with an extensive complication registration system

scientific article published on 10 August 2005

Real-time wireless tumor tracking during breast conserving surgery.

scientific article

SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer.

scientific article published in December 2012

Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy.

scientific article published on 9 August 2013

Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer

scientific article published on 05 August 2016

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

scientific article published on 13 February 2009

Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study.

scientific article